[Pindolol in the treatment of arrhythmias caused by exertion].
In this study the anti-arrhythmic effectiveness of pindolol has been tested on ventricular effort arrhythmias in a group of 22 cardiopathic patients. The drug, administered for a week at the dose of 5 mg three times a day, obtained positive results due to its beta-blocking action and its intrinsic sympathomimetic activity.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010869:Pindolol / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D010869:Pindolol
Il pindololo nel trattamento delle aritmie da sforzo.